Blood Flow and Vascular Function in Cystic Fibrosis
Completed · Phase 2 · Has a placebo group
Conditions studied: Cystic Fibrosis
In brief
Cystic fibrosis (CF) has many health consequences. A reduction in the ability to perform exercise in patients with CF is related to greater death rates, steeper decline in lung function, and more frequent lung infections. However, the physiological mechanisms for this reduced exercise capacity are unknown. The investigators laboratory recently published the first evidence of systemic vascular dysfunction in patients with CF. Therefore, it is reasonable to suspect that the blood vessels are involved with exercise intolerance in CF. This study will look at how 1) blood flow and 2) artery function contribute to exercise capacity in CF.
Key facts
- Study ID
- NCT02057458
- Run by
- Augusta University
- People needed
- 19
- Starts
- 2014-04-01
- Expected to finish
- 2018-07-01
- Last updated by the study team
- 2020-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Augusta University — Augusta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.